[1]
|
Lederberg, J. (2000) Infectious history. Science, 288, 287-293. doi:10.1126/science.288.5464.287
|
[2]
|
Hammerschmidt, S., Hacker, J. and Klenk, H.-D. (2005) Threat of infection: Microbes of high pathogenic potential—Strategies for detection, control and eradication. International Journal of Medical Microbiology, 295, 141- 151. doi:10.1016/j.ijmm.2005.03.004
|
[3]
|
Fauci, A.S. (2006) Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act. Cell, 124, 665-670.
doi:10.1016/j.cell.2006.02.010
|
[4]
|
Rino, R. (2001) Reverse vaccinology, a genome-based approach to vaccine development. Vaccine, 19, 2688- 2691. doi:10.1016/S0264-410X(00)00554-5
|
[5]
|
Raoult, D., et al. (2000) Cultivation of the bacillus of Whipple’s Disease. New England Journal of Medicine, 342, 620-625. doi:10.1056/NEJM200003023420903
|
[6]
|
Mora, M., et al. (2003) Reverse vaccinology. Drug Discovery Today, 8, 459-464.
doi:10.1016/S1359-6446(03)02689-8
|
[7]
|
M?kel?, P.H. (2000) Vaccines, coming of age after 200 years. FEMS Microbiology Reviews, 24, 9-20.
|
[8]
|
Rappuoli, R. and Covacci, A. (2003) Reverse vaccinology and genomics. Science, 302, 602.
doi:10.1126/science.1092329
|
[9]
|
Baron, M.D., et al. (2005) The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes. Journal of General Virology, 86, 1093-1101.
doi:10.1099/vir.0.80751-0
|
[10]
|
Roop, R.M. (1999) Identification of secondary mutations which enhance and stabilize the attenuation of brucella HTRA Mutants: Improving brucella HTRA-based strains as vaccine. University Medical Center, Louisiana State University, Shreveport.
|
[11]
|
Cookson, S., et al. (2005) Monitoring dynamics of single-cell gene expression over multiple cell cycles. Molecular Systems Biology, 1, 1-6.
doi:10.1038/msb4100032
|
[12]
|
Groisman, A., et al. (2005) A microfluidic chemostat for experiments with bacterial and yeast cells. Nature Methods, 2, 685-689. doi:10.1038/nmeth784
|
[13]
|
Sparvero, L.J., et al. (2007) Proteomic analysis of the amyloid precursor protein fragment C99: Expression in yeast. Analytical Biochemistry, 370, 162-170.
doi:10.1016/j.ab.2007.07.033
|